Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.53 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | SNCA | P37840 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2371986 | 0.85 | ALDH1A1 (0.51) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 | |
| SCHEMBL9313156 | 0.84 | TDP1 (0.67) | ALDH1A1CYP1A2TDP1CYP3A4KMT2A | |
| SCHEMBL10915411 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 | |
| SCHEMBL8085472 | 0.80 | ALDH1A1 (0.55) | ALDH1A1CYP1A2TDP1CYP3A4KMT2A | |
| SCHEMBL10914621 | 0.79 | ALDH1A1 (0.54) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 | |
| SCHEMBL10914381 | 0.79 | KMT2A (0.46) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 | |
| SCHEMBL5328095 | 0.79 | CYP3A4 (0.53) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 | |
| SCHEMBL11434065 | 0.79 | CYP3A4 (0.53) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 | |
| SCHEMBL5328091 | 0.79 | CYP3A4 (0.53) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 | |
| SCHEMBL11309120 | 0.79 | ALDH1A1 (0.46) | ALDH1A1CYP1A2CYP3A4KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322715-A1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-10-12 | — | — | US | disclosed |
| US-20230219894-A1 | DISUBSTITUTED ADAMANTYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FOR SUPPRESSING CANCER GROWTH COMPRISING SAME AS ACTIVE INGREDIENT | ONECUREGEN CO., LTD. (KR) | 2023-07-13 | — | — | US | disclosed |
| CN-104203944-B | Multi-fluorescent substance containing coumarin derivative and diagnostic LED light source micro-fluorescence quantitative biosensor using same | 点标生物股份有限公司 | 2017-03-01 | — | — | CN | disclosed |
| CN-102749806-B | Colored curable resin composition | 住友化学株式会社 | 2016-10-26 | — | — | CN | disclosed |
| US-9354234-B2 | Multi-fluorescent substance including novel coumarin derivative, and LED light source-based microfluorescent quantitative biosensor for diagnosis using same | GENBODY INC. (KR) | 2016-05-31 | — | — | US | disclosed |
| US-9354234-B2 | Multi-fluorescent substance including novel coumarin derivative, and LED light source-based microfluorescent quantitative biosensor for diagnosis using same | GENBODY INC. (KR) | 2016-05-31 | — | — | US | disclosed |
| US-9354234-B2 | Multi-fluorescent substance including novel coumarin derivative, and LED light source-based microfluorescent quantitative biosensor for diagnosis using same | GENBODY INC. (KR) | 2016-05-31 | — | — | US | disclosed |
| CN-102838578-B | Salt and cured composition for color | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2016-03-16 | — | — | CN | disclosed |
| CN-102618085-B | Salt and dyestuff | SUMITOMO CHEMICAL CO., LTD. (JP) | 2015-11-25 | — | — | CN | disclosed |
| CN-104203944-A | Multi-fluorescent substance containing novel coumarin derivative and LED light source micro-fluorescence quantitative biosensor for diagnosis using same | ACCOBIOTECH SDN BHD | 2014-12-10 | — | — | CN | disclosed |
| EP-1798216-A1 | INTERMEDIATE OF 6-SUBSTITUTED-1-METHYL-1-H-BENZIMIDAZOLE DERIVATIVE AND METHOD FOR PRODUCING SAME | Sankyo Company, Limited (JP) | 2007-06-20 | — | — | EP | disclosed |
| CN-1084327-C | Method for preparing amino-phenol | CIBA SC HOLDING AG (CH) | 2002-05-08 | — | — | CN | disclosed |
| EP-0831081-B1 | Production of aminophenols | CIBA SC HOLDING AG (CH) | 2000-11-02 | — | — | EP | disclosed |
| US-5908961-A | UNDER AQUEOUS ACIDIC CONDITIONS; CONTINUOUS MONITORING OFPH | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-06-01 | — | — | US | disclosed |
| CN-1178785-A | Method for preparing amino-phenol | CIBA GEIGY AG (CH) | 1998-04-15 | — | — | CN | disclosed |
| EP-0831081-A1 | Production of aminophenols | Ciba SC Holding AG (CH) | 1998-03-25 | — | — | EP | disclosed |
| EP-0176161-A1 | Novel fluoran compounds and production and use thereof | TAOKA CHEMICAL CO., LTD (JP) | 1986-04-02 | — | — | EP | disclosed |
| US-4231963-A | ETHERIFICATION OF ALKALI METAL AMINOPHENOLATE | IHARA CHEMICAL INDUSTRY COMPANY, LIMITED (JP) | 1980-11-04 | — | — | US | disclosed |
| EP-0005451-A2 | Process for the manufacture of cationic oxazinic compounds, the oxazinic compounds and their application to the dyeing and printing of textile materials | CIBA-GEIGY AG (CH) | 1979-11-28 | — | — | EP | disclosed |
| US-4124640-A | FORM HYDROXYANILINE AND ALKYL HALIDE, NONPROTONIC ORGANIC SOLVENT | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1978-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219894-A1 | DISUBSTITUTED ADAMANTYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION FOR SUPPRESSING CANCER GROWTH COMPRISING SAME AS ACTIVE INGREDIENT | AK2, CS, GOT2 | ALDH1A1 509/4885CYP1A2 3405/4885TDP1 1373/4885 |
| US-20230322715-A1 | BROAD SPECTRUM ANTI-CANCER COMPOUNDS | YTHDF1, YTHDF3, YTHDF2 | ALDH1A1 4553/4885CYP1A2 4669/4885TDP1 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.